JPMorgan Chase & Co. Reiterates €28.40 Price Target for AXA (EPA:CS)
Several other analysts also recently commented on the stock. Goldman Sachs Group reaffirmed a hold rating and issued a $8.40 price objective on shares of Deutsche Bank in a report on Monday. Deutsche Bank dropped their price objective on shares of from GBX 217 ($2.84) to GBX 175 ($2.29) and set a sell rating on the stock in a report on Monday, June 24th. HSBC dropped their price objective on shares of Canada Goose from C$62.00 to C$55.00 and set a buy rating on the stock in a report on Monday, June 3rd. Royal Bank of Canada reaffirmed a sector perform rating and issued a GBX 485 ($6.34) price objective on shares of in a report on Tuesday. Finally, Barclays upped their price objective on shares of Zimmer Biomet from $113.00 to $117.00 and gave the company an underweight rating in a report on Monday, April 15th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company currently has an average rating of Buy and a consensus price target of €26.56 ($30.89).
EPA CS opened at €23.64 ($27.49) on Tuesday. The stock’s 50 day moving average price is €22.84. AXA has a 52 week low of €22.13 ($25.73) and a 52 week high of €27.69 ($32.20).
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
Recommended Story: Understanding Compound Annual Growth Rate (CAGR)
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.